Projecting the Long-Term Impact of School- or Community-Based Mass-Treatment Interventions for Control of Schistosoma Infection

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  Wang, Xiaoxia ^a   Gurarie, David ^a   Mungai, Peter L ^b   Muchiri, Eric M ^c   Kitron, Uriel ^d   King, Charles H ^b,e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ministry of Public Health and Sanitation   (Kenya)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ARTICLE; CLINICAL TRIAL (TOPIC); HEALTH CARE COST; HUMAN; INFECTION CONTROL; INFECTION RISK; MASS IMMUNIZATION; PARASITE TRANSMISSION; PATIENT ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; RURAL POPULATION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SNAIL; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PREVALENCE; SCHISTOSOMIASIS; SCHISTOSOMICIDES; TREATMENT OUTCOME;

EID: 84870761341     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001903     Document Type: Article

References (55)

1. WHO Expert Committee (2004) The World Health Report 2004-Changing History. Geneva: World Health Organization. 96 p.
2. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Sachs SE, et al. (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria- A comprehensive pro-poor health policy and strategy for the developing world. Plos Medicine 3: 576-584.
3. Chitsulo L, Engels D, Montresor A, Savioli L, (2000) The global status of schistosomiasis and its control. Acta Trop 77: 41-51.
4. Jordan P (1985) Schistosomiasis: The St. Lucia Project. Cambridge: Cambridge University Press.
5. Utzinger J, Zhou XN, Chen MG, Bergquist R, (2005) Conquering schistosomiasis in China: the long march. Acta Trop 96: 69-96.
6. Laamrani H, Mahjour J, Madsen H, Khallaayoune K, Gryseels B, (2000) Schistosoma haematobium in Morocco: moving from control to elimination. Parasitol Today 16: 257-260.
7. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, et al. (2007) Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 85: 91-99.
8. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. (2009) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
9. Knopp S, Stothard JR, Rollinson D, Mohammed KA, Khamis IS, et al. (2011) From morbidity control to transmission control: time to change tactics against helminths on Unguja Island, Zanzibar. Acta Trop (in press).
10. Jiang QW, Wang LY, Guo JG, Chen MG, Zhou XN, et al. (2002) Morbidity control of schistosomiasis in China. Acta Tropica 82: 115-125.
11. Chen M, Feng Z, (1999) Schistosomiasis control in China. Parasitology International 48: 11-19.
12. Seto EY, Remais JV, Carlton EJ, Wang S, Liang S, et al. (2011) Toward sustainable and comprehensive control of schistosomiasis in China: lessons from Sichuan. PLoS Negl Trop Dis 5: e1372.
13. Spear RC, Seto EY, Carlton EJ, Liang S, Remais JV, et al. (2011) The challenge of effective surveillance in moving from low transmission to elimination of schistosomiasis in China. Int J Parasitol 41: 1243-1247.
14. Andrade ZA, (1998) The situation of hepatosplenic schistosomiasis in Brazil today. Memorias do Instituto Oswaldo Cruz 93: 313-316.
15. Barbosa CS, Araujo KC, Sevilla MA, Melo F, Gomes EC, et al. (2010) Current epidemiological status of schistosomiasis in the state of Pernambuco, Brazil. Mem Inst Oswaldo Cruz 105: 549-554.
16. WHO (2006) Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization.
17. King CH, Dangerfield-Cha M, (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illness 4: 65-79.
18. Gurarie D, Wang X, Bustinduy AL, King CH, (2011) Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis. Am J Trop Med Hyg 84: 773-781.
19. Landoure A, Dembele R, Goita S, Kane M, Tuinsma M, et al. (2012) Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment. PLoS Negl Trop Dis 6: e1774.
20. Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH, (2006) Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg 75: 83-92.
21. SCORE (2012) The Schistosomiasis Consortium for Operational Research and Evalauation. Available: http://score.uga.edu/. Athens, GA: University of Georgia Center for Tropical and Emerging Global Diseases.
22. Gurarie D, King CH, Wang X, (2010) A new approach to modelling schistosomiasis transmission based on stratified worm burden. Parasitology 137: 1951-1965.
23. Gurarie D, Seto EY, (2009) Connectivity sustains disease transmission in environments with low potential for endemicity: modelling schistosomiasis with hydrologic and social connectivities. J R Soc Interface 6: 495-508.
24. Muchiri EM, Ouma JH, King CH, (1996) Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project. Am J Trop Med Hyg 55: 127-134.
25. King CH, Muchiri EM, Ouma JH, (2000) Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerging Infectious Diseases 6: 585-594.
26. Fenwick A, (2006) New initiatives against Africa's worms. Trans R Soc Trop Med Hyg 100: 200-207.
27. Anderson RM, May RM (1991) Infectious Diseases of Humans. Dynamics and Control. New York: Oxford University Press. 467-496, 507-420 p.
28. MacDonald G, (1965) The dynamics of helminth infections, with special reference to schistosomes. Trans R Soc Trop Med Hyg 59: 489-506.
29. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, et al. (1988) Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 39: 295-305.
30. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, et al. (1990) Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587-595.
31. Muchiri EM (1991) Association of water contact activities and risk of reinfection for S. haematobium after drug treatment in the Msambweni Area, Kenya [MS thesis, Epidemiology and Biostatistics]. Cleveland: Case Western Reserve University. 1-121 p.
32. Standley CJ, Adriko M, Alinaitwe M, Kazibwe F, Kabatereine NB, et al. (2009) Intestinal schistosomiasis and soil-transmitted helminthiasis in Ugandan schoolchildren: a rapid mapping assessment. Geospat Health 4: 39-53.
33. Clennon JA, Mungai PL, Muchiri EM, King CH, Kitron U, (2006) Spatial and temporal variations in local transmission of Schistosoma haematobium in Msambweni, Kenya. Am J Trop Med Hyg 75: 1034-1041.
34. Kariuki HC, Clennon JA, Brady MS, Kitron U, Sturrock RF, et al. (2004) Distribution patterns and cercarial shedding of Bulinus nasutus and other snails in the Msambweni area, Coast Province, Kenya. Am J Trop Med Hyg 70: 449-456.
35. Sturrock RF, Kinyanjui H, Thiongo FW, Tosha S, Ouma JH, et al. (1990) Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya. Trans R Soc Trop Med Hyg 84: 257-261.
36. Hamburger J, Hoffman O, Kariuki HC, Muchiri EM, Ouma JH, et al. (2004) Large-scale, polymerase chain reaction-based surveillance of Schistosoma haematobium DNA in snails from transmission sites in coastal Kenya: A new tool for studying the dynamics of snail infection. Am J Trop Med Hyg 71: 765-773.
37. Bustinduy AL, Thomas CL, Fiutem JJ, Parraga IM, Mungai PL, et al. (2011) Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric. PLoS Negl Trop Dis 5: e1213.
38. Peters PAS, Mahmoud AAF, Warren KS, Ouma JH, Siongok TKA, (1976) Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ 54: 159-162.
39. King CH, Mahmoud AAF, (1989) Drugs 5 Years Later- Praziquantel. Annals of Internal Medicine 110: 290-296.
40. Wilson RA, van Dam GJ, Kariuki TM, Farah IO, Deelder AM, et al. (2006) The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates. Int J Parasitol 36: 1241-1244.
41. Chan MS, Bundy DA, (1997) Modelling the dynamic effects of community chemotherapy on patterns of morbidity due to Schistosoma mansoni. Trans R Soc Trop Med Hyg 91: 216-220.
42. Chan MS, Guyatt HL, Bundy DAP, Booth M, Fulford AJ, et al. (1995) The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect 115: 325-344.
43. Molyneux DH, Hotez PJ, Fenwick A, (2005) "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2: e336.
44. Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. 425 p.
45. Brooker S, Kabatereine NB, Myatt M, Russell Stothard J, Fenwick A, (2005) Rapid assessment of Schistosoma mansoni: the validity, applicability and cost-effectiveness of the Lot Quality Assurance Sampling method in Uganda. Trop Med Int Health 10: 647-658.
46. Guyatt H, Brooker S, Lwambo NJ, Siza JE, Bundy DA, (1999) The performance of school-based questionnaires of reported blood in urine in diagnosing Schistosoma haematobium infection: patterns by age and sex. Trop Med Int Health 4: 751-757.
47. Lengeler C, Kilima P, Mshinda H, Morona D, Hatz C, et al. (1991) Rapid, low-cost, two-step method to screen for urinary schistosomiasis at the district level: the Kilosa experience. Bull World Health Organ 69: 179-189.
48. Guyatt HL, Tanner M, (1996) Different approaches to modeling the cost-effectiveness of schistosomiasis control. Am J Trop Med Hyg 55: 159-164.
49. Singer BH, Ryff CD, (2007) Neglected tropical diseases, neglected data sources, and neglected issues. PLoS Negl Trop Dis 1: e104.
50. Hussein MH, Talaat M, El-Sayed MK, El-Badawi A, Evans DB, (1996) Who misses out with school-based health programmes? a study of schistosomiasis control in Egypt. Trans R Soc Trop Med Hyg 90: 362-365.
51. Clennon JA, King CH, Muchiri EM, Kariuki HC, Ouma JH, et al. (2004) Spatial patterns of urinary schistosomiasis infection in a highly-endemic area of coastal Kenya. Am J Trop Med Hyg 70: 443-448.
52. Liese B, Rosenberg M, Schratz A, (2010) Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet 375: 67-76.
53. Mafe MA, Appelt B, Adewale B, Idowu ET, Akinwale OP, et al. (2005) Effectiveness of different approaches to mass delivery of praziquantel among school-aged children in rural communities in Nigeria. Acta Trop 93: 181-190.
54. Mekheimar SI, Talaat M, (2005) School non-enrollment and its relation with health and schistosomiasis knowledge, attitudes and practices in rural Egypt. East Mediterr Health J 11: 392-401.
55. Black CL, Mwinzi PN, Muok EM, Abudho B, Fitzsimmons CM, et al. (2010) Influence of exposure history on the immunology and development of resistance to human schistosomiasis mansoni. PLoS Negl Trop Dis 4: e637.